SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005794-10-000047
Filing Date
2010-03-12
Accepted
2010-03-11 17:36:17
Documents
8
Period of Report
2010-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PROVECTUS PHARMACEUTICALS 8-K provectus8_k.htm 8-K 60926
2 CERTIFICATE OF DESIGNATION exhibit3_1.htm EX-3.1 98256
3 FORM OF SECURITIES PURCHASE AGREEMENT exhibit10_1.htm EX-10.1 188010
4 FORM OF WARRANT exhibit10_2.htm EX-10.2 95454
5 FORM OF REGISTRATION RIGHTS AGREEMENT exhibit10_3.htm EX-10.3 100217
6 PRESS RELEASE exhibit99_1.htm EX-99.1 11262
7 PRESS RELEASE exhibit99_2.htm EX-99.2 14359
8 prove.jpg GRAPHIC 3156
  Complete submission text file 0001005794-10-000047.txt   574939
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS PHARMACEUTICALS INC (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-09410 | Film No.: 10675058
SIC: 2834 Pharmaceutical Preparations